ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,609.97
0.31%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. MiMedx Group Inc (MDXG)

  7. MiMedx Group Inc (MDXG) 뉴스

MDXG MiMedx Group Inc

6.27
0.025 (0.40%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
MiMedx Group Inc MDXG 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.025 0.40% 6.27 05:02:39
개장가 저가 고가 종가 전일 종가
6.25 6.17 6.315 6.27 6.245
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202421:00GLOBEMIMEDX to Host First Quarter 2024 Operating and Financial..
27/03/202421:00GLOBEMIMEDX Provides Update on AXIOFILL® Request for Designation..
20/03/202420:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
13/03/202421:00GLOBEMIMEDX Introduces E-Commerce and Account Management Platform
06/03/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/03/202422:11EDGAR2Form 8-K - Current report
04/03/202422:00GLOBEMIMEDX Announces Appointment of Two New Independent..
29/02/202406:22EDGAR2Form 8-K - Current report
29/02/202406:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/02/202406:01GLOBEMIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
22/02/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202405:55EDGAR2Form 144 - Report of proposed sale of securities
20/02/202422:00GLOBEMIMEDX to Present at TD Cowen 44th Annual Health Care..
17/02/202406:37EDGAR2Form 144 - Report of proposed sale of securities
17/02/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202405:11EDGAR2Form 144 - Report of proposed sale of securities
15/02/202406:13EDGAR2Form 144 - Report of proposed sale of securities
12/02/202422:00GLOBEMIMEDX to Host Fourth Quarter and Full Year 2023 Operating..
22/01/202422:09EDGAR2Form 8-K - Current report
22/01/202422:00GLOBEMIMEDX Announces Improved Capital Structure with New Senior..
30/12/202307:00GLOBEMIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year..
29/12/202306:30EDGAR2Form 8-K - Current report
28/12/202322:00GLOBEMIMEDX Announces Conversion of Outstanding Series B..
28/12/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202306:42EDGAR2Form SC 13D/A - General statement of acquisition of..
23/11/202307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:14EDGAR2Form 8-K - Current report
13/11/202322:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
02/11/202321:00GLOBEMIMEDX to Highlight Published Data at SAWC Fall
31/10/202305:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202305:05EDGAR2Form 8-K - Current report
31/10/202305:01GLOBEMIMEDX Announces Third Quarter 2023 Operating and Financial..
16/10/202321:00GLOBEMIMEDX to Host Third Quarter 2023 Operating and Financial..
26/09/202321:00GLOBEMIMEDX Announces Launch of EPIEFFECT™
06/09/202306:00EDGAR2Form 8-K - Current report
05/09/202321:38EDGAR2Form 8-K - Current report
05/09/202321:00GLOBEMIMEDX to Present at Upcoming Investor Conferences
02/08/202305:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/08/202305:03EDGAR2Form 8-K - Current report
02/08/202305:01GLOBEMIMEDX Announces Second Quarter 2023 Operating and Financial..
26/07/202305:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/07/202305:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/07/202321:00GLOBEMIMEDX to Host Second Quarter 2023 Operating and Financial..
11/07/202321:30GLOBEMIMEDX Announces Favorable Ruling in Putative Securities..
07/07/202307:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/07/202307:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/07/202322:02EDGAR2Form 8-K - Current report
05/07/202321:00GLOBEMIMEDX Appoints Doug Rice as Chief Financial Officer

최근 히스토리

NASDAQ
MDXG
MiMedx
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유